Enrolling by invitationNCT01382082
Assessment of Cognitive Function in Breast Cancer and Lymphoma Patients Receiving Chemotherapy
Studying Lymphoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Rochester NCORP Research Base
- Principal Investigator
- Michelle C. Janelsins, PhDUniversity of Rochester
- Enrollment
- 1432 enrolled
- Eligibility
- 21 years · All sexes
- Timeline
- 2011 – 2026
Study locations (29)
- Delaware/Christiana Care NCORP, Newark, Delaware, United States
- Delaware/Christiana Care NCORP (CHRISTIANA), Newark, Delaware, United States
- Heartland, Decatur, Illinois, United States
- Kansas City Clinical Oncology Program, Prairie Village, Kansas, United States
- Wichita NCORP, Wichita, Kansas, United States
- Wichita, Wichita, Kansas, United States
- Gulf South MU-NCORP, New Orleans, Louisiana, United States
- Cancer Research Consortium of West Michigan, Grand Rapids, Michigan, United States
- CRCWM, Grand Rapids, Michigan, United States
- Metro Minnesota NCORP, Minneapolis, Minnesota, United States
- Metro Minnesota Community Oncology Research Consortium, Saint Louis Park, Minnesota, United States
- CCOP - Nevada Cancer Research Foundation, Las Vegas, Nevada, United States
- Nevada, Las Vegas, Nevada, United States
- Hem Onc CNY, East Syracuse, New York, United States
- Kansas City, Rochester, New York, United States
- +14 more locations on ClinicalTrials.gov
Collaborators
National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01382082 on ClinicalTrials.govOther trials for Lymphoma
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07372352Zeprumetostat, Azacitidine Combined With Lipo-MIT in R/R PTCLThe First Affiliated Hospital of Soochow University
- RECRUITINGPHASE1NCT07198087A Study to Investigate the Pharmacokinetics of Tirabrutinib in Participants With Mild, Moderate, and Severe Hepatic Impairment Compared to Healthy ParticipantsOno Pharmaceutical Co. Ltd
- RECRUITINGNANCT07191431A Clinical Study on the Efficacy and Safety of Methotrexate (MTX) or Thiotepa (for MTX Intolerance) or Temozolomide (TMZ) Combined With Orelabrutinib and Selinexor in Relapsed/Refractory Primary or Secondary Central Nervous System Lymphoma（SELINA）Ruijin Hospital
- RECRUITINGPHASE1, PHASE2NCT07018752A Platform Trial Evaluating New Drugs or Combination in R/R Peripheral T-cell LymphomasThe Lymphoma Academic Research Organisation
- RECRUITINGNANCT07058064WATCH (Wearable Artificial inTelligence for Cardiac Function and Health Monitoring)Mayo Clinic
- RECRUITINGPHASE1NCT06699771Phase 1 to Investigate the Safety, Tolerability, and Efficacy of GCC2005 in Patients With R/R NK and T-cell MalignanciesGC Cell Corporation
- RECRUITINGPHASE2NCT06530550PI3K Inhibitors for the Treatment of Relapsed/Refractory Indolent T/NK-cell LymphomasInstitute of Hematology & Blood Diseases Hospital, China
- RECRUITINGNANCT06296368DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology ClinicsUNC Lineberger Comprehensive Cancer Center